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Myocardial growth in response to mechanical and neurohumoral stimuli In most cases heart failure is the fatal result of chronic pressure or volume overload due to valvar disease, arterial hypertension, and myocardial infarction. 1 The myocardium responds to an increase in load-that is, in wall stress, by development of hypertrophy. This might be considered to be a compensatory response, as according to the law of Laplace, myocardial wall stress decreases with increasing wall thickness. Although in some way adaptive, part of this response is pathological in that it is associated with abnormalities in both diastolic and systolic function and by still unknown mechanisms, may ultimately lead to myocardial failure. With the development of failure the disease process that was initially localised at the heart generalises and many organs will be affected by activation of the renin-angiotensin system and the sympathetic nervous system. In the case of an aetiology other than pressure or volume overload, such as dilated cardiomyopathy, the initial pathological process in the myocardium is less well understood. With the development of failure, the consecutive changes seem to be rather uniform and independent of the aetiology.
Myocardial hypertrophy and failure involve quantitative and qualitative modifications of the genomic expression. In quantitative changes, there is an overall increase in the cardiac expressions of most genes, which finally leads to myocyte hypertrophy and fibroblast hyperplasia. Superimposed on this global response, qualitative changes in gene expression include a positive and negative modulation of cardiac specific genes and a shift in the expression of several isogenes towards a programme partially comparable with that expressed in the fetal heart (table) .
Recently some of the mechanical stimuli, hormones, and growth factors that induce the quantitative and qualitative changes of gene expression as well as their subcellular pathways have been elucidated. Generally, the process of hypertrophy involves the expression of "immediate early genes" and "late responsive genes". The late responsive genes include the cardiac specific genes. The immediate early genes such as the protooncogenes c-myc, c-fos, c-jun, etc, the mRNA of which may be increased as early as several minutes after exposure to the stimulus, code for a rather complex group of oncoproteins that seem to induce and control gene expression in a rather non-specific way."3 32 33 The As AII mediated induction of gene expression closely resembles the situation when mechanical stress is applied to myocytes it might be speculated that local production of growth factor AII may be involved in stress induced myocyte hypertrophy.
This hypothesis is supported by molecular analyses showing mRNA expression of all elements of the renin-angiotensin system in peripheral organs including the heart.4445
Moreover, enhanced myocardial mRNA expression for angiotensinogen and angiotensin converting enzyme (ACE) was found in several models of cardiac hypertrophy.4647 Enhanced expression of ACE mRNA was also found in human hearts with end stage ischaemic or dilated cardiomyopathy.48
As well as AII induced myocyte hypertrophy and fibroblast hyperplasia, interstitial fibrosis may also be mediated by an angiotensin induced rise in circulating aldosterone. 49 Modulation of cardiac specific gene expression in the failing heart CONTRACTILE PROTEINS
The key element of development of myocardial force or shortening is the crossbridge cycle, in which the myosin crossbridge head attaches to actin, rotates in a manner that develops force or causes shortening with thick and thin filaments sliding past each other, and then detaches from the actin filament to start another crossbridge cycle. Alterations in the number of the crossbridges activated or the characteristics of the individual crossbridge cycle may have profound effects on the contractile performance of the heart muscle.
The total number of crossbridges available for activation may be reduced due to replacement of contractile proteins by connective tissue. This situation may be the prominent finding in ischaemic cardiomyopathy after a myocardial infarction. A substitution of contractile material by connective tissue may be of some relevance in other causes of heart failure as well. Hitzel et al in a morphometric study in control hearts described a nonmuscle tissue content of the myocardium of 4%26 Non-muscle tissue content was increased to 23% in dilated cardiomyopathy and 25% in pressure overloaded myocardium. Accordingly, when the myosin content was quantified biochemically, a decrease of 20% was found in dilated cardiomyopathy.50 From these data it was concluded that the decrease in contractile protein content is less important in the contractile deficit of the failing heart than is disturbed crossbridge activation due to altered excitation-contraction coupling processes.50
Profound alterations to the characteristics of the individual crossbridge cycle have been found in animal models of myocardial hypertrophy. [51] [52] [53] [54] [55] [56] In these studies reduced activity of myosin ATPase or myofibrillar ATPase, maximum shortening velocity, and increased economy of isometric force development occurred in the hypertrophied myocardium. The Hasenfiuss, 3'ust phied or in failing human myocardium.2425 As no shift in the myosin heavy chain isoforms is found in the human ventricular myocardium alterations of crossbridge behaviour may be related to changes in the light chains2627 or in thin filament regulatory systems. 29 The alterations to the behaviour of the individual crossbridge cycle found in the hypertrophied and failing myocardium may have two different consequences to myocardial function: (a) prolonged crossbridge attachment may be beneficial for economy of myocardial contraction, as a greater forcetime integral is produced per unit of high energy phosphate hydrolysed; (b) prolonged crossbridge attachment may result in reduced rates of relaxation and reduced shortening velocity, and may prevent the myocardium from developing high power output.55 56 The relevance of altered crossbridge behaviour to systolic or diastolic dysfunction of the failing heart is as yet unknown. It should be mentioned that alterations in crossbridge behaviour similar to those found in the hypertrophied and failing myocardium, occur with aging in patients without heart failure.50
EXCITATION-CONTRACTION COUPLING
From experiments performed in isolated human myocardium, there is considerable evidence that alteration of the excitationcontraction coupling processes may be an important defect in the failing human heart. Excitation-contraction coupling comprises all processes involved in calcium turnover and calcium activation of contractile proteins.606' Calcium, which enters the cell through the L type voltage gated calcium channel during the action potential, acts on the sarcoplasmic reticulum to release a larger amount of calcium through the ryanodine sensitive calcium release channel. The subsequent calcium binding to the regulatory protein troponin C facilitates actomyosin interaction. Calcium is removed from the cytosol predominantly by Ca2+ ATPases of the sarcoplasmic reticulum. Also, calcium is removed by the sarcolemmal Na+ -Ca2+ exchanger and by the sarcolemmal Ca2+ ATPase, which, however, seems to be of minor relevance for calcium homeostasis of the myocyte.6263
Recently considerable work has been performed in analysing the function of the various components of the excitation-contraction coupling system in the human heart. It is still unclear whether or not altered density or function of the L type sarcolemmal calcium channel may be relevant to the failing human heart. Dihydropyridine binding studies and functional measurements Reduced mRNA expression of the ryanodine receptor (sarcoplasmic reticulum calcium release channel) has been found in ischaemic cardiomyopathy, whereas no significant changes in expression have been described in dilated cardiomyopathy.5 Functional measurements with a modified voltage-clamp technique of isolated sarcoplasmic reticulum calcium release channels suggested normal function in failing human myocardium from dilated cardiomyopathic hearts.'6 Another study that used caffein stimulation, however, indicated altered gating properties of this channel in dilated cardiomyopathy. 17 There are several studies that show that expression of sarcoplasmic reticulum Ca2+ ATPase is reduced at the levels of mRNA and protein in failing human myocardium from hearts with ischaemic and dilated cardiomyopathy.'4 1819 Accordingly, reduced sarcoplasmic reticulum calcium reuptake in the failing human heart was suggested from 45Ca2+ uptake measurements in homogenates from human myocardium.20 This was not found in another study.2' The different results of the two studies may be related to experimental differences, as the first study was performed in ventricular homogenates and the second in highly purified vesicles of the sarcoplasmic reticulum. The activity of the sarcoplasmic reticulum Ca2+ ATPase is controlled by the regulator protein phospholamban. No data are available on phospholamban protein concentrations in the failing human heart; however, recent mRNA measurements indicated that phospholamban may decrease in parallel with sarcoplasmic reticulum Ca2+ ATPase in the failing myocardium.'522 Taken together, there is considerable evidence that calcium transport capacity of the sarcoplasmic reticulum may be impaired in the failing human heart, which might be significant pathophysiologically.
From the total amount of calcium cycling during a contraction-relaxation cycle, most is believed to be released and absorbed by the sarcoplasmic reticulum and a little seems to cross the sarcolemmal membrane. This might be different under some pathological conditions when calcium removal by the saroplasmic reticulum is impaired. Reinecke et 90 Therefore, intracellular calcium and contractile force are assumed to be similar at low stimulation rates in both the failing and nonfailing myocardium but are significantly reduced in the failing myocardium at higher exhibited rates of stimulation. It is important to note ;ingly, in that even in the failing myocardium, which ind peak shows a pronounced decline in force developnot dif-ment at higher stimulation rates, only small on-failing changes of diastolic tension were found.70 ierformed The potential clinical relevance of the s of stim-altered force-frequency relation in the failing is signifi-myocardium has been outlined in two studies.
ardium.Y It was shown that during right atrial or venthe same tricular pacing the maximum rate of rise in in results pressure increases at higher heart rates only in ctile pro-patients with normal left ventricular function lreduced but does not change in patients with dilated :ordingly, cardiomyopathy.7'72 Furthermore, it was s in iso-shown that the cardiac index increases at d a pro-higher, right ventricular pacing rates in calcium patients with normal left ventricular function, tolic cal-and declines in patients with failing dilated g human cardiomyopathy (fig 3) .
As the altered force-frequency relation of the failing human heart may be of pathophysiologial and therapeutic relevance further studies were conducted to evaluate the underlying ** subcellular defects. With the photoprotein aequorin, we recently showed that in the nonfailing myocardium the frequency dependent increase in contractile force is associated with increasing intracellular calcium concentration * and that the inverse force-frequency relation of the failing myocardium goes parallel with a frequency dependent decline of the intracellular calcium signal.7' From these findings, there is considerable evidence that disturbed calcium release is an important defect underlying the altered force-frequency relation of the thy failing human heart. Disturbed calcium release could result from a decreased amount of trigger Ca2+ entering the cell through the L * in)
It should be pointed out that uptake of cal- group.bmj.com on April 6, 2017 -Published by http://heart.bmj.com/ Downloaded from cium into the sarcoplasmic reticulum could also be impaired as a consequence of lack of energy in the failing myocardium, which may result from disturbed mitochondrial function. 74 This, however, was not obvious from myothermal measurements that indicated unaltered efficiency of metabolic recovery processes in the failing human myocardium.50
If an insufficient capacity of the sarcoplasmic reticulum to accumulate calcium at higher rates of stimulation is the cause of reduced systolic calcium release, and thus reduced tension development, one would expect diastolic calcium to rise. This in turn would result in diastolic activation of contractile proteins, and thus would cause a rise in diastolic tension. As even at the highest stimulation frequency the rise of diastolic tension was inconsistent in the failing human myocardium,70 alternative mechanisms to remove calcium from the cytosol and prevent diastolic activation of contractile proteins must exist. An alternative to calcium removal by the sarcoplasmic reticulum is that calcium could be removed from the cytosol by mitochondria, which have the potential to accumulate high amounts of calcium and which have been suggested to be involved in the control of intracellular calcium homeostasis. The benefit of long-term treatment with inotropic agents that increase cyclic AMP, such as catecholamines and phosphodiesterase inhibitors, is questionable. Moreover, several studies indicated increased mortality of patients with congestive heart failure under long-term treatment with inotropic agents.8'85
The reasons for the unfavourable long-term effects of cyclic AMP increasing inotropic agents are speculative, but factors such as increased myocardial oxygen consumption, increased heart rate, and calcium overload of the myocyte may be relevant.
DIGITALIS GLYCOSIDES
In contrast with catecholamines and phosphodiesterase inhibitors, the cyclic AMP independent digitalis glycosides seem to have favourable effects on symptoms and haemodynamics during long-term treatment in patients with congestive heart failure.8"88 This might in part result from the decrease in sympathetic tone, increase in parasympathetic tone, reduction of heart rate, and increase in inotropic state. 
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